pioglitazone has been researched along with retinol palmitate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Al Majali, K; Betteridge, DJ; Cooper, MB; Luc, G; Staels, B; Taskinen, MR | 1 |
1 trial(s) available for pioglitazone and retinol palmitate
| Article | Year |
|---|---|
The effect of sensitisation to insulin with pioglitazone on fasting and postprandial lipid metabolism, lipoprotein modification by lipases, and lipid transfer activities in type 2 diabetic patients.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Diet; Diterpenes; Fatty Acids, Nonesterified; Female; Health; Humans; Insulin; Lipid Metabolism; Lipoprotein Lipase; Lipoproteins; Liver; Male; Middle Aged; Pioglitazone; Retinyl Esters; Thiazolidinediones; Triglycerides; Vitamin A | 2006 |
2 other study(ies) available for pioglitazone and retinol palmitate
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |